NEOD

SE0021615655

Advanced Medical Equipment & Technology

Delayed Nasdaq Stockholm Other stock markets 07:14:17 24/05/2024 pm IST			5-day change	1st Jan Change
1 ^SEK	0.00%		+0.20%	-54.55%

25/04	NeoDynamics AB Announces CFO Changes	CI
15/04	Air Astana Partner with Italy-based Neos	MT

NeoDynamics AB announced that it expects to receive SEK 14 million in funding from Gryningskust Holding AB

March 01, 2023

NeoDynamics AB (publ) announced a private placement of convertible loan for proceeds of SEK 14 million on March 1, 2023. The loan is converted into Shares. The loan matures on 15 August 2023.

Latest news about NEOS AB

NeoDynamics AB Announces CFO Changes	25/04	CI
Air Astana Partner with Italy-based Neos	15/04	MT
NeoDynamics AB Announces Appointment of Matilda Salén as Its New Chief Executive Officer	22/03	CI
Anna Eriksrud Announces Desire to Retire as CEO of NeoDynamics AB	29/02	CI
NeoDynamics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	16/02	CI
NeoDynamics AB Reports Earnings Results for the Full Year Ended December 31, 2023	16/02	CI
NeoDynamics AB Announces CFO Aaron Wong to Leave by End of May 2024	13/12	CI
Neodynamics Launches Device Registry in Germany, Cost-Effective Collection of Real-World Data	11/12	CI
NeoDynamics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28/11	CI
NeoDynamics Announces Cost Reduction Plan	13/11	CI
NeoDynamics AB Receives New Order from Western Rhineland-Palatinate Hospital in Germany	18/23/18	CI
NeoDynamics Soars 42% Amid First US Order for Invasive Biopsy System NeoNavia	09/23/09	MT
NeoDynamics AB Receives First Commercial Order from Top University Hospital	09/23/09	CI
NeoDynamics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	31/23/31	CI
Neodynamics AB Presents Results of Pulse Study At the Annual Congress of the German Society of Senology, Munich	10/23/10	CI
NeoDynamics Plans SEK72 Million Rights Issue to Fund Commercialization, Marketing Operations	23/23/23	MT
NeoDynamics AB Reports Earnings Results for the First Quarter Ended March 31, 2023	11/23/11	CI
NeoDynamics AB Presents Final Data Set from NeoDynamics' Pulse Study Presented at the SBI Breast Imaging Symposium	05/23/05	CI
Sweden’s NeoDynamics Launches New Biopsy Technology in US	27/23/27	MT
Neodynamics, Inc. Announces U.S. Availability of Neonavia, the First and Only Pulse Biopsy Technology, Fda-Cleared in Breast and Axillary Lymph Node Biopsies	27/23/27	CI
Neodynamics AB Announces Delivery of Corepulse Needles to 23 Hospitals	03/23/03	CI
NeoDynamics Receives Chinese Patent for NeoNavia FlexiPulse	06/23/06	MT
NeoDynamics AB Receives Chinese Patent for FlexiPulse Needle Design	06/23/06	CI
NeoDynamics AB announced that it expects to receive SEK 14 million in funding from Gryningskust Holding AB	01/23/01	CI
NeoDynamics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	17/23/17	CI

NeoDynamics AB (publ) is a Sweden-based company engaged in the medical industry. The Company focuses on developing and commercializing products for breast cancer screening, imaging, and breast cancer treatments. The Companyâs product NeoNavia, enables a pulse biopsy system for ultrasound guided tissue sampling. It consists of a base unit, a handheld driver and three different types of biopsy needles. Each needle type is driven by the pulse technology providing a more controlled needle insertion and precise placement of the needle in the tumour whilst enabling tissue samples from both breasts and lymph nodes. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden. NeoNavia is evaluated for breast cancer diagnosis at clinics in United Kingdom, Germany, and Sweden.

Sector

Advanced Medical Equipment & Technology

Calendar

20/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for NEOS AB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
NEOS AB	-54.55%	30.37L
SARTORIUS AG	-24.01%	1.76TCr
QUIDELORTHO CORPORATION	-43.22%	280.28Cr
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+18.67%	187.9Cr
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-10.21%	154.59Cr
BIOTAGE AB	+33.28%	133.97Cr
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-21.01%	94Cr
CONTEC MEDICAL SYSTEMS CO.,LTD	-24.92%	86Cr
REVENIO GROUP OYJ	+5.23%	82Cr
VAREX IMAGING CORPORATION	-28.29%	60Cr

Medical Diagnostic & Testing Equipment

NEOS AB

Equities

NEOD

SE0021615655

Advanced Medical Equipment & Technology

NeoDynamics AB announced that it expects to receive SEK 14 million in funding from Gryningskust Holding AB

Latest news about NEOS AB

Chart NEOS AB

Company Profile

Income Statement Evolution

Ratings for NEOS AB

Quarterly revenue - Rate of surprise

Sector Medical Diagnostic & Testing Equipment